{{chembox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 300995705
| ImageFile=Menogaril.png
| ImageSize=200px
| IUPACName=
| OtherNames=7-''O''-Methylnogarol
|Section1={{Chembox Identifiers
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = 8JSV4O30HQ
| CASNo_Ref = {{cascite|correct|??}}
| CASNo=71628-96-1
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1234391
| PubChem = 5288818
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 4450900
| SMILES = C[C@@]1(C[C@H](C2=C(C3=C(C=C2C1)C(=O)C4=C5C(=CC(=C4C3=O)O)[C@@]6([C@@H]([C@H]([C@@H]([C@H](O5)O6)O)N(C)C)O)C)O)OC)O
| InChI = 1/C28H31NO10/c1-27(36)8-10-6-11-16(21(32)15(10)14(9-27)37-5)22(33)17-13(30)7-12-24(18(17)20(11)31)38-26-23(34)19(29(3)4)25(35)28(12,2)39-26/h6-7,14,19,23,25-26,30,32,34-36H,8-9H2,1-5H3/t14-,19+,23+,25-,26-,27-,28-/m1/s1
| InChIKey = LWYJUZBXGAFFLP-OCNCTQISBR
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C28H31NO10/c1-27(36)8-10-6-11-16(21(32)15(10)14(9-27)37-5)22(33)17-13(30)7-12-24(18(17)20(11)31)38-26-23(34)19(29(3)4)25(35)28(12,2)39-26/h6-7,14,19,23,25-26,30,32,34-36H,8-9H2,1-5H3/t14-,19+,23+,25-,26-,27-,28-/m1/s1
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = LWYJUZBXGAFFLP-OCNCTQISSA-N
  }}
|Section2={{Chembox Properties
| Formula=C<sub>28</sub>H<sub>31</sub>NO<sub>10</sub>
| MolarMass=541.55 g/mol
| Appearance=
| Density=
| MeltingPt=
| BoilingPt=
| Solubility=
  }}
|Section3={{Chembox Hazards
| MainHazards=
| FlashPt=
| AutoignitionPt =
  }}
}}

'''Menogaril''' is an [[anthracycline]] analog of [[nogalamycin]] which was developed in late 1970s. It has even stronger anticancer activity than nogalamycin and has less toxicity than nogalamycin. However, its development for clinical use was cancelled.<ref name="Moore 1999">{{cite journal | title=Phase II trial of menogaril in non-Hodgkin's lymphomas: a Southwest Oncology Group trial. |author1=Moore DF Jr |author2=Brown TD |author3=LeBlanc M |author4=Dahlberg S |author5=Miller TP |author6=McClure S |author7=Fisher RI. | journal=Invest New Drugs. | year=1999 | volume=17 | issue=2 | pages=169â€“72 | doi=10.1023/A:1006375301205}}</ref>

== References ==
<references/>

[[Category:Anthracyclines]]


{{antineoplastic-drug-stub}}